简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2012-10-25 10:17 Policy Makers Join the Call for the Prevention of Atrial Fibrillation-Related Strokes to be Made a National Healthcare Priority
2012-10-24 15:56 Quintiles Expands Patient Access for Clinical Trials to Indonesia
2012-10-19 14:41 GE Healthcare Connects People through Music in Fight Against Breast Cancer with First Health Initiative powered by Spotify
2012-10-17 15:30 WIN Consortium and Oracle Join Forces to Accelerate Personalized Cancer Care
2012-10-17 12:32 Major Breakthrough in Malaria Reduction, and Reduction of Mosquito Bites Now Possible with New Receptor-Blocking Chemical Technologyc
2012-10-17 10:00 Cegedim Relationship Management Releases Mobile Intelligence 8, Groundbreaking Cloud-Based CRM + CLM + Data Platform
2012-10-15 20:00 Eppendorf Announces New Brunswick CelliGen® BLU cabinet / 50L CelliGen® BLU vessel
2012-10-15 18:16 FAB’ENTECH launches a Phase I clinical trial in Singapore for its new product against H5N1 Avian Influenza
2012-10-12 12:08 Covidien Announces Final Results from Landmark DEFINITIVE LE Study in Patients with Peripheral Arterial Disease
2012-10-10 20:00 Analysis Group, Inc., Opens Office in Beijing, Extending Global Reach of Health Economics Research and Consulting Services
2012-10-10 17:46 ZELTIQ® Aesthetics to Showcase CoolCurve+ Applicator at IMCAS Asia Hong Kong 2012
2012-10-09 16:57 PENTAX Medical Announces Debut of Next Generation High Definition (HD+) Endoscopic Platform
2012-10-09 15:40 Terumo BCT Launches $100,000 Grant with New Blood Safety Innovation Award
2012-10-09 15:13 Delphi Genetics Grants Merck License for the Use of the StabyExpress™ System
2012-10-09 14:38 Cybex Promotes Women’s Fitness, Raises Funds for Breast Cancer Research in 4th Annual Pink Ribbon Run
2012-10-09 14:29 Quintiles, dabl Team to Advance Cardiovascular Safety Assessment
2012-10-09 14:20 ABRAXANE Meets Primary Endpoint of Progression-Free Survival in Phase III Chemotherapy-Naïve Metastatic Melanoma Study
2012-10-09 12:27 New Ophthalmic Imaging Product Integrates Advanced Eye Exam Technology with iPhone™ Application
2012-10-08 16:56 Mallinckrodt Completes Acquisition of CNS Therapeutics, Inc.
2012-10-08 16:17 Phase IIb Data Showed Merck’s Investigational Once-Weekly DPP-4 Inhibitor MK-3102 Significantly Lowered Blood Sugar in Patients with Type 2 Diabetes

Business Wire Weibo

Press Releases

Latest Releases